330 related articles for article (PubMed ID: 11384606)
1. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.
Takahashi LK; Ho SP; Livanov V; Graciani N; Arneric SP
Brain Res; 2001 Jun; 902(2):135-42. PubMed ID: 11384606
[TBL] [Abstract][Full Text] [Related]
2. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist.
Heinrichs SC; De Souza EB; Schulteis G; Lapsansky JL; Grigoriadis DE
Neuropsychopharmacology; 2002 Aug; 27(2):194-202. PubMed ID: 12093593
[TBL] [Abstract][Full Text] [Related]
3. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.
Radulovic J; Rühmann A; Liepold T; Spiess J
J Neurosci; 1999 Jun; 19(12):5016-25. PubMed ID: 10366634
[TBL] [Abstract][Full Text] [Related]
4. Effects of transgenic overproduction of CRH on anxiety-like behaviour.
van Gaalen MM; Stenzel-Poore MP; Holsboer F; Steckler T
Eur J Neurosci; 2002 Jun; 15(12):2007-15. PubMed ID: 12099906
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450.
Chaki S; Nakazato A; Kennis L; Nakamura M; Mackie C; Sugiura M; Vinken P; Ashton D; Langlois X; Steckler T
Eur J Pharmacol; 2004 Feb; 485(1-3):145-58. PubMed ID: 14757135
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
[TBL] [Abstract][Full Text] [Related]
7. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
Skórzewska A; Lehner M; Hamed A; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Płaźnik A
Behav Brain Res; 2011 Aug; 221(1):155-65. PubMed ID: 21376756
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
Lu L; Liu D; Ceng X
Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
[TBL] [Abstract][Full Text] [Related]
10. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor receptors in the dorsal raphe nucleus modulate social behavior in Syrian hamsters.
Cooper MA; Huhman KL
Psychopharmacology (Berl); 2007 Oct; 194(3):297-307. PubMed ID: 17581742
[TBL] [Abstract][Full Text] [Related]
12. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
Cipriano AC; Gomes KS; Nunes-de-Souza RL
Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
[TBL] [Abstract][Full Text] [Related]
14. The blockage of ventromedial hypothalamus CRF type 2 receptors impairs escape responses in the elevated T-maze.
Silva MSCF; Souza TMO; Pereira BA; Ribeiro DA; Céspedes IC; Bittencourt JC; Viana MB
Behav Brain Res; 2017 Jun; 329():41-50. PubMed ID: 28435125
[TBL] [Abstract][Full Text] [Related]
15. Anxiogenic-like effect of corticotropin-releasing factor receptor 2 antisense oligonucleotides infused into rat brain.
Isogawa K; Akiyoshi J; Tsutsumi T; Kodama K; Horinouti Y; Nagayama H
J Psychopharmacol; 2003 Dec; 17(4):409-13. PubMed ID: 14870953
[TBL] [Abstract][Full Text] [Related]
16. The behavioural and electrophysiological effects of CRF in rat frontal cortex.
Zieba B; Grzegorzewska M; Brański P; Domin H; Wierońska JM; Hess G; Smiałowska M
Neuropeptides; 2008; 42(5-6):513-23. PubMed ID: 18617263
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor and defensive withdrawal: inhibition of monoamine oxidase prevents habituation to chronic stress.
Ward HE; Johnson EA; Goodman IJ; Birkle DL; Cottrell DJ; Azzaro AJ
Pharmacol Biochem Behav; 1998 May; 60(1):209-15. PubMed ID: 9610944
[TBL] [Abstract][Full Text] [Related]
18. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats.
Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H
Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
Todorovic C; Radulovic J; Jahn O; Radulovic M; Sherrin T; Hippel C; Spiess J
Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007
[TBL] [Abstract][Full Text] [Related]
20. Role of NPY Y1 receptor on acquisition, consolidation and extinction on contextual fear conditioning: dissociation between anxiety, locomotion and non-emotional memory behavior.
Lach G; de Lima TC
Neurobiol Learn Mem; 2013 Jul; 103():26-33. PubMed ID: 23603424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
